DNA Q2 2021 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena

DNAGinkgo Bioworks Holdings, Inc.

$418M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$44M+329.4% YoY

Gross Profit

$27M60.8% margin

Operating Income

-$60M-137.4% margin

Net Income

-$54M-123.6% margin

EPS (Diluted)

$-1.67

QoQ Revenue Growth

-1.0%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$59M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$587M

Total Liabilities

$231M

Stockholders' Equity

$349M

Cash & Equivalents

$236M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$10M	+329.4%
Gross Profit	$27M	$10M	+161.0%
Operating Income	-$60M	-$31M	-93.0%
Net Income	-$54M	-$29M	-88.2%